Skip to main content

Business Intelligence

HIMSS24
By HIMSS TV | 03:20 pm | March 19, 2024
Healthcare management consulting company J29's Tracy Mills, CEO and founder, and Nick Vass, president, talk about their work providing clinical policy and data analysis for public agencies, as well as their support of the “HIMSS Gives Back” program.  
HIMSS24
By HIMSS TV | 06:00 am | March 18, 2024
Dr. Maria Carolina Aguirre, CMIO at FCV-HIC (Hospital Internacional de Colombia), discusses her efforts with HL7 to encourage Colombia's diverse regions to work together on digital health projects and use interoperability standards.  
HIMSS24
By HIMSS TV | 03:43 pm | March 15, 2024
AI-powered tools are being developed, implemented or at least considered by nearly every health system worldwide, says HIMSS President and CEO Hal Wolf. Hear more from industry insiders and leaders as they discuss key takeaways from the 2024 HIMSS Global Health Conference & Exhibition in Orlando.  
By Jeff Lagasse | 11:35 am | March 07, 2024
The expanded health system now operates 19 hospitals and 130 outpatient locations with nearly 14,000 team members.
By Jeff Lagasse | 11:50 am | March 05, 2024
Alloyed Works delivers solutions that streamline benefits management and creates new revenue streams, says Highmark.
By Jeff Lagasse | 09:56 pm | March 01, 2024
The offering also provides additional digital health and wellbeing offerings, such as 30-minute pickup and same-day prescription delivery.
By Jeff Lagasse | 11:45 am | March 01, 2024
The program will provide access to coaching and wellness tools to help participants manage their weight goals.
By Jeff Lagasse | 11:40 am | March 01, 2024
Traditional monitoring methods can incur unnecessary costs and potentially extra steps, Signify says.
By Jeff Lagasse | 12:11 pm | February 29, 2024
The organizations say their combined strengths will help to advance the level of care for patients in New York and Connecticut.
By HIMSS TV | 06:00 am | February 29, 2024
Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health, says the acquisition of drug-diversion company Invistics is helping to route appropriate medications to the right patients.